Cheng C - Search Results

1

A combination of intrinsic and extrinsic features improves prognostic prediction in malignant pleural mesothelioma.

Nguyen TT, Lee HS, Burt BM, Amos CI, Cheng C. Nguyen TT, et al. Among authors: cheng c. Br J Cancer. 2022 Nov;127(9):1691-1700. doi: 10.1038/s41416-022-01950-z. Epub 2022 Aug 23. Br J Cancer. 2022. PMID: 35999269 Free PMC article.

2

Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.

Cai G, Xiao F, Cheng C, Li Y, Amos CI, Whitfield ML. Cai G, et al. Among authors: cheng c. PLoS One. 2017 Apr 20;12(4):e0175850. doi: 10.1371/journal.pone.0175850. eCollection 2017. PLoS One. 2017. PMID: 28426704 Free PMC article.

3

A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.

Zhao Y, Varn FS, Cai G, Xiao F, Amos CI, Cheng C. Zhao Y, et al. Among authors: cheng c. Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):86-95. doi: 10.1158/1055-9965.EPI-17-0478. Epub 2017 Nov 15. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29141854 Free PMC article.

4

Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy.

Varn FS, Tafe LJ, Amos CI, Cheng C. Varn FS, et al. Among authors: cheng c. Oncoimmunology. 2018 Mar 15;7(6):e1431084. doi: 10.1080/2162402X.2018.1431084. eCollection 2018. Oncoimmunology. 2018. PMID: 29872556 Free PMC article.

5

Identification of gene expression levels in primary melanoma associated with clinically meaningful characteristics.

Gorlov I, Orlow I, Ringelberg C, Hernando E, Ernstoff MS, Cheng C, Her S, Parker JS, Thompson CL, Gerstenblith MR, Berwick M, Amos C. Gorlov I, et al. Among authors: cheng c. Melanoma Res. 2018 Oct;28(5):380-389. doi: 10.1097/CMR.0000000000000473. Melanoma Res. 2018. PMID: 29975213 Free PMC article.

6

A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.

Zhao Y, Schaafsma E, Gorlov IP, Hernando E, Thomas NE, Shen R, Turk MJ, Berwick M, Amos CI, Cheng C. Zhao Y, et al. Among authors: cheng c. Mol Cancer Res. 2019 Jan;17(1):109-119. doi: 10.1158/1541-7786.MCR-18-0173. Epub 2018 Aug 31. Mol Cancer Res. 2019. PMID: 30171176 Free PMC article.

7

Statins associate with improved mortality among patients with certain histological subtypes of lung cancer.

Ung MH, MacKenzie TA, Onega TL, Amos CI, Cheng C. Ung MH, et al. Among authors: cheng c. Lung Cancer. 2018 Dec;126:89-96. doi: 10.1016/j.lungcan.2018.10.022. Epub 2018 Oct 25. Lung Cancer. 2018. PMID: 30527197 Free PMC article.

8

Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma.

Kamal Y, Cheng C, Frost HR, Amos CI. Kamal Y, et al. Among authors: cheng c. Oncoimmunology. 2018 Oct 16;8(1):e1500106. doi: 10.1080/2162402X.2018.1500106. eCollection 2019. Oncoimmunology. 2018. PMID: 30546942 Free PMC article.

9

A gene expression-based immune signature for lung adenocarcinoma prognosis.

Wang L, Luo X, Cheng C, Amos CI, Cai G, Xiao F. Wang L, et al. Among authors: cheng c. Cancer Immunol Immunother. 2020 Sep;69(9):1881-1890. doi: 10.1007/s00262-020-02595-8. Epub 2020 May 5. Cancer Immunol Immunother. 2020. PMID: 32372138 Free PMC article.

10

An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors.

Cheng C, Zhao Y, Schaafsma E, Weng YL, Amos C. Cheng C, et al. Int J Cancer. 2020 Nov 1;147(9):2621-2633. doi: 10.1002/ijc.33053. Epub 2020 Jun 4. Int J Cancer. 2020. PMID: 32406930 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,312 results

Search Page

Filters